NPR : News

Filed Under:

FDA Ratchets Down On Prescribing Of OxyContin And Other Opioids

The Food and Drug Administration today took another step toward restricting use of OxyContin and other powerful and often-abused prescription pain medications.

The move comes amid an emotional debate over so-called long-acting opioid analgesics. Federal health officials and others are concerned about the rising number of Americans who are getting addicted to the drugs and overdosing on them. Pain specialists and their patients, however, fear that restrictions risk making it too hard for patients who need the drugs to get them.

In announcing the new requirements, Hamburg told reporters that the agency is trying to balance the dangers of abuse with the needs of patients.

"The FDA is invoking its authority to require safety labeling changes and post-market studies to combat the crisis of misuse, abuse, addiction, overdose and death from these potent drugs that have harmed too many patients and devastated too many families and communities," FDA Commissioner Margaret A. Hamburg said in a statement.

"Today's action demonstrates the FDA's resolve to reduce the serious risks of long-acting and extended release opioids while still seeking to preserve appropriate access for those patients who rely on these medications to manage their pain," Hamburg said.

Among the changes is a warning to doctors that the drugs should only be prescribed for "pain severe enough to require daily, around-the-clock, long-term" treatment, Hamburg said. Currently, the drugs are recommended for patients with "moderate to severe" pain.

In addition, under the new guidelines the drugs should be "reserved" for patients "for whom alternative treatment options are ineffective, not tolerated or would be otherwise inadequate to provide sufficient management of pain," Hamburg said.

At the same time, the agency is requiring a new label directed at pregnant women. The prominent "boxed" warning labels will warn that chronic use of the drugs by pregnant women can cause a life-threatening complication in their babies known as neonatal opioid withdrawal syndrome. Newborns go through withdrawal because they are no longer exposed to an addictive drug.

The agency also is demanding that companies that make the drugs conduct more studies to assess the risks associated with using the drugs, including addiction, abuse and fatal overdoses.

Copyright 2013 NPR. To see more, visit http://www.npr.org/.

NPR

'I'm Supposed To Protect You From All This' Is Memoir Fraught With Mystery

Nadja Spiegelman — daughter of graphic novelist Art Spiegelman and New Yorker art editor Françoise Mouly — has written a memoir about her mother, her grandmother, and their flawed family memories.
NPR

Salvage Supperclub: A High-End Dinner In A Dumpster To Fight Food Waste

The ingredients — think wilted basil, bruised plums, garbanzo bean water — sound less than appetizing. Whipped together, they're a tasty meal that show how home cooks can use often-tossed foods.
NPR

#NPRreads: These Three Stories Are A Real Catch

Correspondents, editors and producers from our newsroom share the pieces that have kept them reading, using the #NPRreads hashtag. Each weekend, we highlight some of the best stories.
NPR

How Your Health Data Lead A Not-So-Secret Life Online

Apps can make managing health care a lot easier, but most don't have the privacy protections required of doctors and hospitals. And a simple Web search can clue in advertisers to health concerns.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.